Document is current
Any future updates will be listed below
-
Authors
Evon, Donna M.
Golin, Carol E.
Stoica, Teodora
Jones, Rachel E.
Willis, Sarah J.
Galanko, Joseph
Fried, Michael W.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK089004-04, DK034987, K24DK066144)
Office of AIDS Research (K24HD06920, P30 AI-50410)
- License Information
-
More Information
Article History
First Online: 23 November 2016
Compliance with Ethical Standards
:
: Funding to support this study was provided to Donna M. Evon (K23DK089004-04), Carol E. Golin (K24HD06920), Joseph Galanko (DK034987), and Michael W. Fried (K24DK066144). Additional support was provided by the University of North Carolina at the Chapel Hill Center for AIDS Research (P30 AI-50410).
: Carol E. Golin, Teodora Stoica, Rachel Jones, Sarah Willis, and Joseph Galanko declare that they have no conflict of interests to disclose. Donna M. Evon has served as an ad hoc consultant and received an honorarium from Gilead. Michael W. Fried has received research funding from and served as a consultant for AbbVie, BMS, Gilead, and Merck.
: All procedures performed in this study involving human participants were in accordance with ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable standards.
: Informed consent was obtained from all individual participants included in the study.
